Liposomal delivery of the rna genome of a live-attenuated chikungunya virus vaccine candidate provides local, but not systemic protection after one dose

HIGHLIGHTS

• who: Mehfuz Zaman and Adam Taylor from the The Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Australia, Institute for Glycomics, Griffith University, Australia have published the paper: Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose, in the Journal: (JOURNAL)
• what: This study provides the basis for developing CAF01-mediated delivery of replicationcompetent RNA as a vaccine strategy.
• how: Flow cytometry data were analyzed using FlowJo software (v10.6 Treestar Inc.). CAF01 Delivers Replication . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.